Can You Take METHOCARBAMOL with Gabapentin?

Severity assessment

Moderate. Co-administration of gabapentin and methocarbamol can lead to additive central nervous system (CNS) depression, increasing the risk of side effects such as excessive sedation, dizziness, confusion, and potentially respiratory depression [1] [2].

Mechanism (plain English)

Both gabapentin and methocarbamol depress the central nervous system. Gabapentin reduces nerve excitability, aiding in seizure control and neuropathic pain. Methocarbamol, a muscle relaxant, acts as a general CNS depressant, slowing overall brain activity. When combined, their individual CNS depressant effects are additive, intensifying drowsiness, reducing alertness, and potentially slowing breathing [1] [2].

Evidence level

Regulator-flagged. This interaction is noted in professional drug information databases [1], and general warnings regarding CNS depressant effects are present in FDA labels for both gabapentin [2] and methocarbamol [3].

Top regulator advisories (cite verbatim or close paraphrase)

• TGA (Australia): No specific pair-specific public advisory exists. Australian product information for gabapentin includes warnings about CNS depressant effects and cautions against concomitant use with other CNS depressants.
• MHRA / NICE (UK): The MHRA has strengthened warnings for gabapentinoids (including gabapentin) regarding addiction, dependence, withdrawal, and tolerance. They advise healthcare professionals to discuss treatment strategies, including safe discontinuation, and to be aware of increased risks when gabapentinoids are combined with other CNS depressants.
• FDA / CDC (US): The FDA prescribing information for gabapentin (Neurontin) notes increased concentrations with morphine, potentially requiring dose adjustment, and warns of somnolence/sedation and dizziness [2]. The FDA label for methocarbamol (Robaxin) cautions that it is a general CNS depressant and advises against combined use with alcohol and other CNS depressants [3].
• EMA (Europe): No specific pair-specific public advisory found. The EMA has reviewed methocarbamol-containing products, confirming their benefit-risk balance for short-term muscle spasm treatment. General warnings regarding CNS depressant interactions are applicable.

Clinical risk factors that elevate the danger

• Elderly patients: Increased susceptibility to CNS depression due to age-related physiological changes, including decreased renal function [2] [3].
• Patients with respiratory compromise: Higher risk of respiratory depression when CNS depressants are combined [1].
• History of substance abuse: Elevated risk of addiction and dependence, particularly with gabapentin.
• Concomitant use of other CNS depressants: Including alcohol, opioids, benzodiazepines, and other sedatives, which significantly enhance CNS depression [1] [2] [3].
• Renal impairment: Both drugs are renally eliminated; impaired kidney function can lead to drug accumulation and increased adverse effects [2] [3].

What a patient should be told

• Increased drowsiness and dizziness: Expect heightened sleepiness, dizziness, and impaired concentration. Avoid driving or operating machinery until you understand how these medications affect you.
• Do not stop abruptly: Never discontinue either medication suddenly without consulting your doctor or pharmacist, as this can trigger withdrawal symptoms or worsen your underlying condition.
• Monitor for warning signs: Be vigilant for extreme drowsiness, confusion, very slow or shallow breathing, or difficulty waking up. Report these symptoms to your healthcare provider immediately.
• Review all medications: Inform your doctor or pharmacist about all other drugs, including over-the-counter medicines, supplements, and alcohol, to ensure a safe treatment plan. They may suggest dose adjustments or safer alternatives.
• Seek urgent care: If you or someone else observes severe drowsiness, significant breathing difficulties, or unresponsiveness, call emergency services without delay.

Top 3 sources (with full citation)

1. Drugs.com. Interactions between Gabapentin and Methocarbamol. URL: https://www.drugs.com/drug-interactions/gabapentin-with-methocarbamol-1147-0-1588-0.html?professional=1
2. U.S. Food and Drug Administration. (2017). NEURONTIN (gabapentin) capsules, tablets, oral solution. Full Prescribing Information. URL: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020235s064_020882s047_021129s046lbl.pdf
3. U.S. Food and Drug Administration. (2003). ROBIAXIN (methocarbamol tablets, USP) 500 mg, 750 mg. Full Prescribing Information. URL: https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/011011Orig1s070s071lbl.pdf

Notes for the reviewing pharmacist

The primary concern with co-administration of gabapentin and methocarbamol is additive CNS depression, particularly in vulnerable populations such as the elderly or those with respiratory compromise. Patient education should strongly emphasize the risks of sedation and respiratory depression, and the importance of avoiding other CNS depressants, including alcohol. The MHRA's recent focus on gabapentinoid dependence and withdrawal also underscores the need for careful patient counseling and tapering strategies if discontinuation is considered.

Source metadata JSON

{
  "pair": "gabapentin + methocarbamol",
  "severity": "Moderate",
  "evidence_level": "Regulator-flagged",
  "source_urls": "https://www.drugs.com/drug-interactions/gabapentin-with-methocarbamol-1147-0-1588-0.html?professional=1;https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020235s064_020882s047_021129s046lbl.pdf;https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/011011Orig1s070s071lbl.pdf"
}